07 August 2024
On July 30, St. Petersburg witnessed the groundbreaking ceremony for the new manufacturing complex of Active Component JSC. The event was attended by representatives from the Ministry of Industry and Trade, Ministry of Health, the St. Petersburg administration, and the pharmaceutical industry. Supported by the Ministry of Industry and Trade under the Cluster Investment Platform, this project aims to enhance import independence in the pharmaceutical sector.
The complex will produce active pharmaceutical ingredients (APIs) for 35 international nonproprietary names listed as essential drugs. These APIs will be used in medications for cancer treatment, organ transplants, cardiovascular diseases, and type 2 diabetes. Key attendees included Deputy Minister of Industry and Trade Ekaterina Priezzheva, Deputy Minister of Health Sergey Glagolev, and Vice-Governor of St. Petersburg Oleg Ergashev.
PrintNovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
Eight radiopharmaceuticals registered in Russia since 2023
10 September 2024
First-in-class combination therapy authorised for endometriosis
10 September 2024
Russian cancer vaccine passes preclinical trials
09 September 2024
Gene therapy trial facilitates major vision improvement
09 September 2024